Search results
COVID-19 is associated with a severe disease course in about 23% and mortality in about 6% of infected persons. Individuals with comorbidities and clinical features associated with severity should be monitored closely, and preventive efforts should especially target those with diabetes, malignancy, and immunosuppression.
COVID-19, an infectious respiratory illness caused by the severe acute respiratory syndrome–corona virus 2 (SARS-CoV2), has now spread to multiple countries including India. The pace at which the disease spread in the last 4 months, since it was first recognized from China, is unprecedented.
On 11 March, the World Health Organization (WHO) declared the coronavirus disease 2019 (COVID‐19) outbreak caused by the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) a pandemic. 1 Currently, the deadly COVID‐19 has no effective therapy or vaccine.
Cases have been reported across all continents since the beginning of the pandemic, with over 776 million confirmed cases and over 7 million deaths reported globally. [17]
Coronavirus disease (COVID-19) is caused by SARS-COV2 and represents the causative agent of a potentially fatal disease that is of great global public health concern. Based on the large number of infected people that were exposed to the wet animal market in Wuhan City, China, it is suggested that this is likely the zoonotic origin of COVID-19.
28 wrz 2023 · COVID-19 Epidemiological Update Edition 159 published 29 September 2023 In this edition: • Key highlights • Global overview • Hospitalizations and ICU admissions • SARS-CoV-2 variants of interest and variants under monitoring • WHO regional overviews
Model Epidemiologiczny ICM opisuje rozwój epidemii COVID-19 w Polsce. Umożliwia on przewidywanie potencjalnych ścieżek dalszego rozwoju epidemii, a także badanie różnych scenariuszy i efektów, jakie wprowadzają dynamicznie stosowane restrykcje administracyjne.
